Skip to main content

Lisa Hensley named director of University of Florida Emerging Pathogens Institute

Internationally recognized infectious disease scientist Lisa E. Hensley, Ph.D., whose career has focused on combating some of the world's most significant biological threats, has been named director of the University of Florida's Emerging Pathogens Institute.

Hensley brings more than two decades of experience advancing vaccines, therapeutics and diagnostics for diseases including Ebola, mpox and COVID-19. Her work has spanned the full pathway from laboratory research to clinical development, helping translate scientific discoveries into tools that improve public health preparedness and response.

“We are fortunate to have Dr. Hensley joining UF to lead the Emerging Pathogen Institute,” said David Norton, UF vice president for research. “Her depth of expertise and experience positions UF to lead the nation in addressing the most pertinent pathogen challenges that face this and future generations.”

Hensley joins UF from the U.S. Department of Agriculture's National Bio and Agro-Defense Facility, where she served as research lead and distinguished senior research scientist. There, she established and led a zoonotic disease research program and helped launch Biosafety Level 4 laboratory capabilities that strengthen the nation's ability to respond to biological threats. Headshot of Lisa Hensley

Prior to joining USDA, Hensley served as associate director for science at the National Institute of Allergy and Infectious Diseases Integrated Research Facility, where she directed research programs focused on emerging infectious diseases and helped advance medical countermeasures into clinical trials. She previously held leadership positions at the U.S. Food and Drug Administration and the U.S. Army Medical Research Institute of Infectious Diseases.

"The challenges posed by emerging infectious diseases are increasingly complex and interconnected," Hensley said. "The University of Florida has built an exceptional environment for collaborative research and innovation. I look forward to working with colleagues across the university to advance discoveries that strengthen preparedness and improve public health."

Hensley has authored more than 275 peer-reviewed scientific publications and has led or contributed to major national and international efforts to prepare for and respond to infectious disease outbreaks.

As director of the Emerging Pathogens Institute, Hensley will lead efforts to expand interdisciplinary research, strengthen partnerships and accelerate scientific discoveries that improve the detection, prevention and treatment of infectious diseases.

Founded in 2006, the Emerging Pathogens Institute brings together researchers from across disciplines to address infectious disease threats affecting people, animals, plants and ecosystems. Through research, education and public engagement, the institute advances scientific solutions that strengthen health security in Florida and beyond.

Hensley will start January 4, 2027.